Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 5, 2004, Pages 841-847

  Conway, Steven P ^a   Etherington, Christine ^a   Peckham, Daniel G ^a   Brownlee, Keith G ^a   Whitehead, Andrew ^a   Cunliffe, Helen ^a  

^a SEACROFT HOSPITAL   (United Kingdom)

Author keywords

Allergic bronchopulmonary aspergillosis; Antifungals; Itraconazole

Indexed keywords

ALANINE AMINOTRANSFERASE; CLARITHROMYCIN; HEMOGLOBIN; HYDROXYITRACONAZOLE; ITRACONAZOLE; OMEPRAZOLE; POTASSIUM; UREA;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASPERGILLUS FUMIGATUS; BIOCHEMISTRY; BLOOD SAMPLING; BRONCHOPULMONARY ASPERGILLOMA; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MALE; MEDICAL ASSESSMENT; NAUSEA AND VOMITING; PHASE 2 CLINICAL TRIAL; SCHOOL CHILD; STEADY STATE;

ADMINISTRATION, ORAL; ADOLESCENT; ANTIFUNGAL AGENTS; AREA UNDER CURVE; BIOTRANSFORMATION; CHILD; CYSTIC FIBROSIS; FEMALE; HALF-LIFE; HUMANS; HYDROXYLATION; ITRACONAZOLE; MALE;

EID: 2442674117     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh175     Document Type: Article

References (16)

1. Mearns, M., Young, W. & Batten, J. (1965). Transient pulmonary infiltrations in cystic fibrosis due to allergic aspergillosis. Thorax 20, 385-92.
2. Geller, D., Kaplowitz, H., Light, M. et al. (1999). Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Chest 116, 639-46.
3. Nepomuceno, I., Esrig, S. & Moss, R. (1999). Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 115, 364-70.
4. Hanley-Lopez, J. & Clement, L. (2000). Allergic bronchopulmonary aspergillosis in cystic fibrosis. Current Opinion in Pulmonary Medicine 6, 540-4.
5. Knutsen, A. & Slavin, R. (1991). Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Clinical Reviews in Allergy 9, 103-18.
6. Denning, D., Van Wye, J., Lewiston, N. et al. (1991). Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100, 813-9.
7. Stevens, D., Schwartz, H., Lee, J. et al. (2000). A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. New England Journal of Medicine 342, 756-62.
8. Lippert, H. & Lehmann, H. P. (1978). SI Units in Medicine: An Introduction to the International System of Units with Conversion Tables and Normal Ranges. 1st edn. Urban & Schwarzenberg, Baltimore-Munich, USA.
9. Becker, J., Burke, W., McDonald, G. et al. (1996). Prevalence of allergic bronchopulmonary aspergillosis and atopy in adult patients with cystic fibrosis. Chest 109, 1536-40.
10. Wojnarowski, C., Eichler, I., Gartner, C. et al. (1997). Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine 155, 1902-7.
11. Mastella, G., Rainisio, M., Harms, H. et al. (2000). Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. European Respiratory Journal 16, 464-71.
12. Salez, F., Brichet, A., Desurmont, S. et al. (1999). Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 116, 1665-8.
13. De Beule, K. & Van Gestel, J. (2001). Pharmacology of itraconazole. Drugs 61, Suppl. 1, 27-37.
14. Boogaerts, M. A., Verhoef, G. E., Zachee, P. et al. (1989). Anti-fungal prophylaxis with itraconazole in prolonged neutropenia: correlation with plasma levels. Mycoses 32, Suppl. 1, 103-8.
15. Sermet-Gaudelus, I., Lesne-Hulin, A., Lenoir, G. et al. (2001). Sputum itraconazole concentrations in cystic fibrosis patients. Antimicrobial Agents and Chemotherapy 45, 1937-8.
16. de Repentigny, L., Ratelle, J., Leclerc, J. et al. (1998). Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children. Antimicrobial Agents and Chemotherapy 42, 404-8.